An Essential Role for the Tumor-Suppressor Merlin in Regulating Fatty Acid Synthesis
- 14 September 2017
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 77 (18) , 5026-5038
Abstract
Neurofibromatosis type 2 (NF2) is an autosomal dominant disorder characterized by the development of multiple tumors in the central nervous system, most notably schwannomas, and meningiomas. Mutational inactivation of the NF2 gene encoding the protein Merlin is found in most sporadic and inherited schwannomas, but the molecular mechanisms underlying neoplastic changes in schwannoma cells remain unclear. We report here that Nf2-deficient cells display elevated expression levels of key enzymes involved in lipogenesis and that this upregulation is caused by increased activity of Torc1. Inhibition or knockdown of fatty acid synthase (FASN), the enzyme that catalyzes the formation of palmitic acid from malonyl-CoA, drove NF2-deficient cells into apoptosis. Treatment of NF2-mutant cells with agents that inhibit the production of malonyl-CoA reduced their sensitivity to FASN inhibitors. Collectively, these results suggest that the altered lipid metabolism found in NF2-mutant cells renders them sensitive to elevated levels of malonyl-CoA, as occurs following blockade of FASN, suggesting new targeted strategies in the treatment of NF2-deficient tumors. Cancer Res; 77(18); 5026–38. ©2017 AACR.Keywords
All Related Versions
This publication has 59 references indexed in Scilit:
- CD43 Promotes Cells Transformation by Preventing Merlin-Mediated Contact Inhibition of GrowthPLOS ONE, 2013
- Targeting cellular metabolism to improve cancer therapeuticsCell Death & Disease, 2013
- Metabolic intervention on lipid synthesis converging pathways abrogates prostate cancer growthOncogene, 2012
- ErbB Expression, Activation, and Inhibition With Lapatinib and Tyrphostin (AG825) in Human Vestibular SchwannomasOtology & Neurotology, 2011
- Fatty Acid Synthase As a Potential Therapeutic Target in CancerFuture Oncology, 2010
- Fatty acid synthase as a novel target for meningioma therapyNeuro-Oncology, 2010
- Merlin/NF2 Suppresses Tumorigenesis by Inhibiting the E3 Ubiquitin Ligase CRL4DCAF1 in the NucleusCell, 2010
- NF2/Merlin Is a Novel Negative Regulator of mTOR Complex 1, and Activation of mTORC1 Is Associated with Meningioma and Schwannoma GrowthMolecular and Cellular Biology, 2009
- SREBP Activity Is Regulated by mTORC1 and Contributes to Akt-Dependent Cell GrowthCell Metabolism, 2008
- Inhibition of fatty acid synthetases by the antibiotic ceruleninBiochemical and Biophysical Research Communications, 1972